Home / Peptide Wiki / Thymosin Alpha-1 (Tα1)
Immune

Thymosin Alpha-1 (Tα1)

Immune Modulator

Thymic peptide and potent immune system modulator. FDA-approved (Zadaxin) in 37 countries for hepatitis B, hepatitis C, and immunodeficiency. Activates dendritic cells, NK cells and Th1 response.

Amino Acids28
Mol. Weight3108.5 Da
Half-Life~2 hours
Availability 🔔 By Request
Amino Acid Sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

What Is Thymosin Alpha-1?

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino-acid peptide derived from prothymosin alpha in thymic tissue. It is approved in 37 countries (as Zadaxin, SciClone) for treatment of hepatitis B, hepatitis C, and immunodeficiency states. It is also under investigation for sepsis and cancer immunotherapy enhancement.

Key Mechanisms

  • Dendritic cell activation — matures immature DCs and enhances antigen presentation
  • Th1 polarisation — shifts immune response toward cellular immunity via IL-12 and IFN-γ production
  • NK cell enhancement — increases natural killer cell cytotoxicity
  • TLR-9 signalling — activates innate immune recognition pathways
  • T-cell maturation — stimulates differentiation of T-cell precursors in thymus and periphery

Key References

  1. Garaci E et al. “Thymosin alpha1 in the treatment of cancer.” Ann N Y Acad Sci, 2012;1270:26–31.
  2. Romani L et al. “Thymosin alpha 1 activates dendritic cell tryptophan catabolism.” J Clin Invest, 2004;114:1579–1588.
🔬

Request Peptide

Fill out the form and we'll get back to you within 24 hours.